Theriva Biologics Past Performance
How has Theriva Biologics performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TOVX is currently unprofitable.
Growing Profit Margin: TOVX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TOVX is unprofitable, but has reduced losses over the past 5 years at a rate of 5% per year.
Accelerating Growth: Unable to compare TOVX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TOVX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (53%).
Return on Equity
High ROE: TOVX has a negative Return on Equity (-33.29%), as it is currently unprofitable.